S127: DELTATP73 IMPOSES TP53 MUTANT-LIKE PHENOTYPES INCLUDING DRUG RESISTANCE AND POOR PROGNOSIS ON TP53-WILD TYPE ACUTE MYELOID LEUKEMIA.

• Diego A Pereira-Martins,
• César Alexander Ortiz Rojas,
• Isabel Weinhauser,
• Douglas Silveira,
• Albertus T J Wierenga,
• Vincent van den Boom,
• Thiago M Bianco,
• Emanuele Ammatuna,
• Lynn Quek,
• Antonio R Lucena-Araujo,
• Gerwin Huls,
• Eduardo Rego,
• Jan Jacob Schuringa

Affiliations

Diego A Pereira-Martins

1 University Medical Centre Groningen, Experimental Hematology, Groningen, The Netherlands

César Alexander Ortiz Rojas

2 Medical School of Ribeirao Preto and the Center for Cell Based Therapy, University of São Paulo, Department of Internal Medicine, Ribeirao Preto, Brazil

Isabel Weinhauser

1 University Medical Centre Groningen, Experimental Hematology, Groningen, The Netherlands

Douglas Silveira

4 King’s College London, Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Albertus T J Wierenga

1 University Medical Centre Groningen, Experimental Hematology, Groningen, The Netherlands

Vincent van den Boom

1 University Medical Centre Groningen, Experimental Hematology, Groningen, The Netherlands

Thiago M Bianco

2 Medical School of Ribeirao Preto and the Center for Cell Based Therapy, University of São Paulo, Department of Internal Medicine, Ribeirao Preto, Brazil

Emanuele Ammatuna

1 University Medical Centre Groningen, Experimental Hematology, Groningen, The Netherlands

Lynn Quek

4 King’s College London, Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Antonio R Lucena-Araujo

5 Federal University of Pernambuco, Genetics, Recife, Brazil

Gerwin Huls

1 University Medical Centre Groningen, Experimental Hematology, Groningen, The Netherlands

Eduardo Rego

2 Medical School of Ribeirao Preto and the Center for Cell Based Therapy, University of São Paulo, Department of Internal Medicine, Ribeirao Preto, Brazil

Jan Jacob Schuringa

1 University Medical Centre Groningen, Experimental Hematology, Groningen, The Netherlands